Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nektar Therapeutics
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Net Income
-$177.1m
CAGR 3-Years
28%
CAGR 5-Years
16%
CAGR 10-Years
-2%
Johnson & Johnson
NYSE:JNJ
Net Income
$14.7B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Net Income
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
12%

See Also

What is Nektar Therapeutics's Net Income?
Net Income
-177.1m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Net Income amounts to -177.1m USD.

What is Nektar Therapeutics's Net Income growth rate?
Net Income CAGR 10Y
-2%

Over the last year, the Net Income growth was 42%. The average annual Net Income growth rates for Nektar Therapeutics have been 28% over the past three years , 16% over the past five years , and -2% over the past ten years .

Back to Top